Thymic output and peripheral T lymphocyte subsets in relapsing-remitting multiple sclerosis patients treated or not by IFN-β

Journal of Neuroimmunology

Volumn 193, Issue 1-2, 2008, Pages 188-194

  Puissant Lubrano, Bénédicte ^a,b   Viala, Frédérique ^c   Winterton, Peter ^a   Abbal, Michel ^a,b   Clanet, Michel ^c   Blancher, Antoine ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b CHU RANGUEIL   (France)

^c CHU PURPAN   (France)

Author keywords

CD45RC; IFN treatment; Multiple sclerosis; Regulatory T cells; T cell subsets; Thymic function

Indexed keywords

BETA INTERFERON; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE COUNT; MALE; MEMORY T LYMPHOCYTE; MULTIPLE SCLEROSIS; PARAMETER; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMUS DISEASE;

ADULT; ANTIGENS, CD45; FEMALE; HUMANS; INTERFERON-BETA; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROTEIN ISOFORMS; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 37749045695     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.10.027     Document Type: Article

References (22)

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology 43 (1993) 655-661
2. Avolio C., Ruggieri M., Cafforio P., Giuliani F., Silvestris F., Dammacco F., Livrea P., and Trojano M. LFA-1 expression on CD4(+)CD45RO(+) peripheral blood T-lymphocytes in RR MS: effects induced by rIFNbeta-1a. J. Neurol. Sci. 186 (2001) 65-73
3. Bielekova B., Richert N., Howard T., Blevins G., Markovic-Plese S., McCartin J., Frank J.A., Wurfel J., Ohayon J., Waldmann T.A., McFarland H.F., and Martin R. Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8705-8708
4. de Andres C., Aristimuno C., de Las Heras V., Martinez-Gines M.L., Bartolome M., Arroyo R., Navarro J., Gimenez-Roldan S., Fernandez-Cruz E., and Sanchez-Ramon S. Interferon beta-1a therapy enhances CD4(+) regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 182 (2007) 204-211
5. Douek D.C., Vescio R.A., Betts M.R., Brenchley J.M., Hill B.J., Zhang L., Berenson J.R., Collins R.H., and Koup R.A. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355 (2000) 1875-1881
6. Gniadek P., Aktas O., Wandinger K.P., Bellmann-Strobl J., Wengert O., Weber A., von Wussow P., Obert H.J., and Zipp F. Systemic IFN-beta treatment induces apoptosis of peripheral immune cells in MS patients. J. Neuroimmunol. 137 (2003) 187-196
7. Goodin D.S. Treatment of multiple sclerosis with human beta interferon. Int. MS J. 12 (2005) 96-108
8. Haas J., Hug A., Viehover A., Fritzsching B., Falk C.S., Filser A., Vetter T., Milkova L., Korporal M., Fritz B., Storch-Hagenlocher B., Krammer P.H., Suri-Payer E., and Wildemann B. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 35 (2005) 3343-3352
9. Hartrich L., Weinstock-Guttman B., Hall D., Badgett D., Baier M., Patrick K., Feichter J., Hong J., and Ramanathan M. Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients. J. Neuroimmunol. 139 (2003) 84-92
10. Hazenberg M.D., Otto S.A., de Pauw E.S., Roelofs H., Fibbe W.E., Hamann D., and Miedema F. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood 99 (2002) 3449-3453
11. Hug A., Korporal M., Schroder I., Haas J., Glatz K., Storch-Hagenlocher B., and Wildemann B. Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J. Immunol. 171 (2003) 432-437
12. Jensen J., Langkilde A.R., Fenst C., Nicolaisen M.S., Roed H.G., Christiansen M., and Sellebjerg F. CD4 T cell activation and disease activity at onset of multiple sclerosis. J. Neuroimmunol. 149 (2004) 202-209
13. Khoury S.J., Guttmann C.R., Orav E.J., Kikinis R., Jolesz F.A., and Weiner H.L. Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis. Arch. Neurol. 57 (2000) 1183-1189
14. Kumar M., Putzki N., Limmroth V., Remus R., Lindemann M., Knop D., Mueller N., Hardt C., Kreuzfelder E., and Grosse-Wilde H. CD4+CD25+FoxP3+T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. J. Neuroimmunol. 180 (2006) 178-184
15. Lassmann H., and Ransohoff R.M. The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal. Trends Immunol. 25 (2004) 132-137
16. Mix E., Stefan K., Hoppner J., Klauer T., Zettl U.K., Strauss U., Meyer-Rienecker H.J., and Rolfs A. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta. Autoimmunity 36 (2003) 291-305
17. Muraro P.A., Leist T., Bielekova B., and McFarland H.F. VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis. J. Neuroimmunol. 111 (2000) 186-194
18. Putheti P., Pettersson A., Soderstrom M., Link H., and Huang Y.M. Circulating CD4+CD25+T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J. Clin. Immunol. 24 (2004) 155-161
19. Seddon B., and Mason D. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC-cells and CD4(+)CD8(-) thymocytes. J. Exp. Med. 189 (1999) 279-288
20. Seddon B., and Mason D. The third function of the thymus. Immunol. Today 21 (2000) 95-99
21. Viglietta V., Baecher-Allan C., Weiner H.L., and Hafler D.A. Loss of functional suppression by CD4+CD25+regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199 (2004) 971-979
22. Zapata J.M., Pulido R., Acevedo A., Sanchez-Madrid F., and de Landazuri M.O. Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages. J. Immunol. 152 (1994) 3852-3861